Implementing The Beacon Platform For The Next Generation Of Cell Line Development

Pharma companies are looking for ways to speed up their biologics to market in order to meet the patients' needs. During this webinar, Dr. Greg Bleck of Catalent Biologics and Dr. Keith Breinlinger of Berkeley Lights discuss the Beacon(R) platform and how it can accelerate cell line development.

Click here to view webinar.